HomeCompareGBLP vs PM

GBLP vs PM: Dividend Comparison 2026

GBLP yields 4000.00% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBLP wins by $7175340620755.82M in total portfolio value
10 years
GBLP
GBLP
● Live price
4000.00%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7175340620755.87M
Annual income
$6,839,006,593,197,835,000.00
Full GBLP calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — GBLP vs PM

📍 GBLP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGBLPPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GBLP + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GBLP pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GBLP
Annual income on $10K today (after 15% tax)
$340,000.00/yr
After 10yr DRIP, annual income (after tax)
$5,813,155,604,218,160,000.00/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, GBLP beats the other by $5,813,155,604,218,158,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GBLP + PM for your $10,000?

GBLP: 50%PM: 50%
100% PM50/50100% GBLP
Portfolio after 10yr
$3587670310377.96M
Annual income
$3,419,503,296,598,918,700.00/yr
Blended yield
95.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

GBLP
No analyst data
Altman Z
-6.7
Piotroski
3/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GBLP buys
0
PM buys
0
No recent congressional trades found for GBLP or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGBLPPM
Forward yield4000.00%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$7175340620755.87M$49.6K
Annual income after 10y$6,839,006,593,197,835,000.00$2,492.02
Total dividends collected$7152397773804.84M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: GBLP vs PM ($10,000, DRIP)

YearGBLP PortfolioGBLP Income/yrPM PortfolioPM Income/yrGap
1← crossover$410,700$400,000.00$11,648$408.29+$399.1KGBLP
2$15,792,720$15,353,271.03$13,589$495.90+$15.78MGBLP
3$568,657,142$551,758,931.89$15,877$603.21+$568.64MGBLP
4$19,176,207,860$18,567,744,718.20$18,580$734.88+$19176.19MGBLP
5$605,696,028,890$585,177,486,479.73$21,781$896.75+$605696.01MGBLP
6$17,922,210,653,594$17,274,115,902,681.27$25,578$1,096.12+$17922210.63MGBLP
7$496,869,793,504,300$477,693,028,104,954.00$30,092$1,342.17+$496869793.47MGBLP
8$12,908,672,105,251,704$12,377,021,426,202,104.00$35,470$1,646.46+$12908672105.22MGBLP
9$314,330,866,876,668,540$300,518,587,724,049,200.00$41,892$2,023.58+$314330866876.63MGBLP
10$7,175,340,620,755,871,000$6,839,006,593,197,835,000.00$49,578$2,492.02+$7175340620755.82MGBLP

GBLP vs PM: Complete Analysis 2026

GBLPStock

Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. The company's principal product line consists of XS CAPSULE (XIN-SHU) for the treatment of angina and other coronary disease; JUTAI SOFT CAPSULE, a dietary supplement; QINGXUAN ANTI-HYPERTENSION TABLET, an over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; and YANREQING TABLET for the treatment of inflammation. It also manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections, and numbness of limbs. The company markets its products through distributors, such as wholesale companies and chain store representatives, as well as through its sales force. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China.

Full GBLP Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this GBLP vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GBLP vs SCHDGBLP vs JEPIGBLP vs OGBLP vs KOGBLP vs MAINGBLP vs MOGBLP vs BTIGBLP vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.